Thailand and GHIT Fund join forces to tackle infectious diseases
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
The collaboration promises expanded funding for Thai universities, research institutes, companies, and global research partners working in Thailand
Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.
Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
Its a major breakthrough for women’s ovarian cancer care in Europe
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
Subscribe To Our Newsletter & Stay Updated